← All organizations

Chiasma, Inc.

For profitWebsite ↗

Also known as: CHIASMA | Chiasma, Inc.

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2012

First marketed drug

Jun 26, 2020

Last known activity

Sep 1, 2017

Acquired by Amryt Research LimitedChiesi on May 5, 2021

Timeline

2000s

  1. Jun 1, 2001

    Chiasma, Inc.— Founded

2020s

  1. Jun 26, 2020

    octreotide— Marketing Organization

  2. May 5, 2021

    Amryt Research Limited— Acquired By

  3. Jan 9, 2023

    Chiesi— Now

Drugs by trial phase (3 distinct, 3 trials)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (3)

Details

Founded
Jerusalem, IL Jun 1, 2001
Last known activity
Sep 1, 2017